Evidence map›Paper›PMID 35504823›Full record

ArticleReumatologia clinica2022

Impact of lung ultrasound during the SARS-CoV-2 pandemic: Distinction between viral and bacterial pneumonia.

Yale Tung-Chen, Alejandro Giraldo Hernández, Alberto Mora Vargas, Laura Dorado Doblado, Patricia Elsa González Merino, Ángela Valencia Alijo, Jesús Herraiz Jiménez, Ángela Gutiérrez Rojas, Sonia García Prieto, Edith Vanesa Gutiérrez Abreu and 1 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Reumatologia clinica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yale Tung-ChenFacultad de Medicina, Universidad Alfonso X El Sabio, Madrid, Spain; Servicio de Medicina de Interna, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain. Electronic address: yale.tung@salud.madrid.org.
Alejandro Giraldo HernándezFacultad de Medicina, Universidad Alfonso X El Sabio, Madrid, Spain.
Alberto Mora VargasServicio de Medicina de Interna, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Laura Dorado DobladoServicio de Medicina de Interna, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Patricia Elsa González MerinoServicio de Medicina de Interna, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Ángela Valencia AlijoServicio de Medicina de Interna, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Jesús Herraiz JiménezServicio de Medicina de Interna, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Ángela Gutiérrez RojasServicio de Medicina de Interna, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Sonia García PrietoServicio de Medicina de Interna, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Edith Vanesa Gutiérrez AbreuServicio de Medicina de Interna, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Esther Montero HernándezServicio de Medicina de Interna, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Universidad Alfonso X el Sabio · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLung Ultrasound is an accessible, low-cost technique that has demonstrated its usefulness in the prognostic stratification of COVID-19 patients. In addition, according to previous studies, it can guide us towards the potential aetiology, especially in epidemic situations such as the current one. PATIENTS AND

methods40 patients were prospectively recruited, 30 with confirmed SARS-CoV-2 pneumonia and 10 with community-acquired pneumonia (CAP). The patients included underwent both a chest X-ray and ultrasound.

resultsThere were no differences in the 2 groups in terms of clinical and laboratory characteristics. The main ultrasound findings in the SARS-CoV-2 group were the presence of confluent B lines and subpleural consolidations and hepatinization in the CAP group. Pleural effusion was more frequent in the CAP group. There were no normal lung ultrasound exams. Analysis of the area under the curve (AUC) curves showed an area under the curve for Lung Ultrasound of 89.2% (95% CI: 75%.0-100%, p < .001) in the identification of SARS-CoV-2 pneumonia. The cut-off value for the lung score of 10 had a sensitivity of 93.3% and a specificity of 80.0% (p < .001). DISCUSSION: The combination of the findings of the Lung Ultrasound, with a Lung Score greater than 10, added to the rest of the additional tests, can be an excellent tool to predict the aetiology of the pneumonia.

Indexed as

COVID-19Pneumonia, BacterialHumansLungPandemicsSARS-CoV-2Community acquired pneumoniaCoronavirus disease 2019Ecografía pulmonarEnfermedad por coronavirus 2019Lung ultrasoundNeumonía adquirida en la comunidadSevere acute respiratory syndrome due to coronavirus type 2Síndrome respiratorio agudo severo por coronavirus tipo 2

Identifiers

PMID35504823
PMCPMC8930392
OpenAlexW4221046137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.